Adamis Pharmaceuticals Corporation, a specialty pharmaceutical company, develops patented vaccine technology to provide protection against various viral infectious agents. It primarily offers vaccines for influenza and hepatitis. The company also offers specialty pharmaceutical products that are sold under a prescription and promoted to physicians who specialize in allergy, respiratory disease, and pediatric medicine. Its products include AeroHist Caplets, AeroHist Plus Caplets, and AeroKid Oral Liquid for the relief of symptoms of seasonal or perennial rhinitis; AeroOtic HC Ear Drops for the treatment of superficial infections of the external auditory canal; Prelone indicated in various diseases and disorders, including allergic states and respiratory diseases; and allergy extracts, sterile vials, and diluents used in preparation of allergy therapy. The company also develops a single-dose epinephrine syringe; and an aerosolized inhaled nasal steroid product for the treatment of seasonal and perennial allergic rhinitis. In addition, it holds intellectual property relating to a portfolio of proprietary product candidates known as microbicides. The company was founded in 2006 and is based in Del Mar, California.
Adamis Pharmaceuticals Corp.
2658 Del Mar Heights Road
Suite 555
Del Mar, CA 92014
United States - Map
Phone: 858-401-3984
Website: http://www.adamispharmaceuticals.com
